Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Shanghai Junshi Bioscience Co., Ltd.
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Fred Hutchinson Cancer Center
Biocity Biopharmaceutics Co., Ltd.
Shouyao Holdings (Beijing) Co. LTD
Qilu Pharmaceutical Co., Ltd.
National Cancer Institute, Naples
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
LigaChem Biosciences, Inc.
Qilu Pharmaceutical Co., Ltd.
BioNTech SE
Jinan Military General Hospital
Adcendo ApS
Suzhou Genhouse Bio Co., Ltd.
AstraZeneca
BioGate Precision Medicine Corp.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Boehringer Ingelheim
Akeso
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Takeda
Jinan Military General Hospital
The First Affiliated Hospital of Xiamen University
Nanolattix Biotechnology Co., Ltd.
Zhejiang University